Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Asset Utilization Ratio (2020 - 2025)

Keros Therapeutics (KROS) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.45 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.45, compared with a TTM value of 0.45 through Dec 2025, changed N/A, and an annual FY2025 reading of 0.51, changed N/A over the prior year.
  • Asset Utilization Ratio was 0.45 for Q4 2025 at Keros Therapeutics, up from 0.32 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.45 in Q4 2025 and bottomed at 0.0 in Q1 2021.
  • Average Asset Utilization Ratio over 4 years is 0.12, with a median of 0.04 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio tumbled 100.0% in 2021, then surged 3870103.85% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.07 in 2021, then soared by 97.9% to 0.15 in 2022, then plummeted by 99.7% to 0.0 in 2023, then surged by 103940.57% to 0.45 in 2025.
  • Business Quant data shows Asset Utilization Ratio for KROS at 0.45 in Q4 2025, 0.32 in Q3 2025, and 0.0 in Q4 2023.